Research and Development of TRPV4 Blockade as a Novel Medical Countermeasure for Acute Respiratory Distress Syndrome due to Chlorine Gas Inihilation
Award Notice Posted
- Solicitation number
- HHSO100201700009C
- Agency
-
Immediate Office of the Secretary
Department of Health and Human Services
- Awarded
- to Glaxosmithkline, LLC
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- HHSO100201700009C Federal IDV award
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- Not on record
Notice details come from SAM.gov. Updated .
Notice text
Cost-Sharing Contract to GLAXOSMITHKLINE, LLC for the Research and Development of TRPV4 under BARDA-CBRN-BAA-16-100-SOL-00001.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity